These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12450575)

  • 1. (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens.
    Pertwee RG; Ross RA; Craib SJ; Thomas A
    Eur J Pharmacol; 2002 Dec; 456(1-3):99-106. PubMed ID: 12450575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens.
    Pertwee RG; Thomas A; Stevenson LA; Maor Y; Mechoulam R
    Neuropharmacology; 2005 Jun; 48(8):1139-46. PubMed ID: 15910889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A; Stevenson LA; Wease KN; Price MR; Baillie G; Ross RA; Pertwee RG
    Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6"-Azidohex-2"-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist.
    Thomas A; Ross RA; Saha B; Mahadevan A; Razdan RK; Pertwee RG
    Eur J Pharmacol; 2004 Mar; 487(1-3):213-21. PubMed ID: 15033394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
    Pertwee RG; Thomas A; Stevenson LA; Ross RA; Varvel SA; Lichtman AH; Martin BR; Razdan RK
    Br J Pharmacol; 2007 Mar; 150(5):586-94. PubMed ID: 17245367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder.
    Pertwee RG; Fernando SR
    Br J Pharmacol; 1996 Aug; 118(8):2053-8. PubMed ID: 8864542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.
    Pertwee RG; Griffin G; Lainton JA; Huffman JW
    Eur J Pharmacol; 1995 Sep; 284(3):241-7. PubMed ID: 8666005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
    Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
    Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
    Duncan M; Kendall DA; Ralevic V
    J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K; Molleman A; Parsons M; Whelan C
    Eur J Pharmacol; 2003 Mar; 464(2-3):207-15. PubMed ID: 12620515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterisation of the CB
    Mazeh AC; Angus JA; Wright CE
    Eur J Pharmacol; 2021 Oct; 909():174433. PubMed ID: 34416240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
    Fride E; Foox A; Rosenberg E; Faigenboim M; Cohen V; Barda L; Blau H; Mechoulam R
    Eur J Pharmacol; 2003 Feb; 461(1):27-34. PubMed ID: 12568912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.
    Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ
    Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
    Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.
    Cascio MG; Gauson LA; Stevenson LA; Ross RA; Pertwee RG
    Br J Pharmacol; 2010 Jan; 159(1):129-41. PubMed ID: 20002104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioassay of cannabinoids using the mouse isolated vas deferens.
    Thomas A; Pertwee RG
    Methods Mol Med; 2006; 123():191-207. PubMed ID: 16506409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids.
    Ihenetu K; Molleman A; Parsons ME; Whelan CJ
    Eur J Pharmacol; 2003 Jan; 458(1-2):207-15. PubMed ID: 12498928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.
    Christopoulos A; Coles P; Lay L; Lew MJ; Angus JA
    Br J Pharmacol; 2001 Mar; 132(6):1281-91. PubMed ID: 11250879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.
    Malinowska B; Godlewski G; Bucher B; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug; 356(2):197-202. PubMed ID: 9272725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.